Find U.S. news and updates from UCB, a global biopharmaceutical company focused on creating value for people living with severe diseases, such as epilepsy, Parkinson’s disease, psoriasis, osteoporosis, myasthenia gravis, rheumatoid arthritis, psoriatic arthritis, non-radiographic axial spondyloarthritis, and more.
